A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic ...

Two international academic journals have found that it is effective to apply classical treatments to patients with advanced ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

Liver cancer, particularly Hepatocellular Carcinoma (HCC), is fast emerging as one of India’s most pressing health challenges ...

The poster presentation, titled "Development of dual-payload anti-GPC3 antibody-drug conjugate by dual-payload antibody conjugation (AD2C) platform for hepatocellular carcinoma treatment ...

Cancer drugs' sexual toxicity warrants a "call to action" among oncologists to address the problem. ( Lancet Oncology) U.S.